App-Quantinova.ai

CHARACTERIZATION OF PURE MEMBRANOUS LUPUS NEPHRITIS: A COHORT OF 134 PATIENTS

L. Silva - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

Oraprine

ADULT NEUROPSYCHIATRIC LUPUS

C. Gordon - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

N/A

PEDIATRIC NEUROPSYCHIATRIC LUPUS

T. Avcin - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

Cyclophosphamide

PULMONARY ARTERIAL HYPERTENSION IN A FEMALE WITH JUVENILE-SLE

M. Rodrigues - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

Mycophenolate mofetil

DIVERSITY IN CLINICAL MANIFESTATIONS OF AUTOINFLAMMATORY SYNDROMES IN A FRENCH PAEDIATRIC RHEUMATOLOGY REFERRAL CENTER

S. Boiu - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Venous thrombosis

canakinumab (SC)

THE RISK OF VENOUS THROMBOEMBOLISM IN PATIENTS WITH RHEUMATOID ARTHRITIS COMPARED TO THE GENERAL POPULATION: A VERY LARGE COHORT STUDY

S.C. Kim - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

N/A

THROMBOEMBOLISM IN RHEUMATOID ARTHRITIS: INCREASED RISKS UNRELATED TO HOSPITALIZATION AND DISEASE DURATION

M. Holmqvist - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

N/A

LYMPHOCYTIC INTERSTITIAL PNEUMONIA IN RHEUMATOID ARTHRITIS

M. Bely - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

N/A

SAFETY OF SURGERY IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED BY RITUXIMAB IN ROUTINE CARE: DATA FROM THE FRENCH AIR REGISTRY

S. Godot - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

Rituximab

POSTOPERATIVE COMPLICATIONS IN RHEUMATOID ARTHRITIS PATIENTS RECEIVING BIOLOGIC AND NONBIOLOGIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS

E. Pogozheva - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

Methotrexate

A FULMINANT CASE OF NECROTISING FASCIITIS SECONDARY TO RITUXIMAB IN A PATIENT WITH RHEUMATOID ARTHRITIS

S. Raghuvanshi - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Venous thrombosis

Methotrexate

ANTI-PHOSPHOLIPID ANTIBODIES IN SYSTEMIC SCLEROSIS: PREVALENCE AND CLINICAL CORRELATIONS

K.B. Morrisroe - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

N/A

TYPE AND INCIDENCE OF SYSTEMIC VASCULITIS IN PROGRESSIVE SYSTEMIC SCLEROSIS

M. Bely - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Venous thrombosis

N/A

THROMBOTIC MICROANGIOPATHY IN RENAL BIOPSIES FROM PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

J. Gerhardsson - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

N/A

HIGH RATE OF CARDIOVASCULAR EVENTS IN LUPUS PATIENTS AT 5 YEAR FOLLOW UP AND ASSOCIATION OF CLASSICAL AND LUPUS RELATED RISK FACTORS

S. Skeoch - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

Cyclophosphamide

EVALUATION OF TWO ASSAYS FOR ANTIPHOSPHOLIPID ANTIBODIES IN 712 SLE PATIENTS; CLINICAL ASSOCIATIONS DEPEND ON ISOTYPES AND CUT-OFF LEVELS

A. Vikerfors - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

N/A

THE EFFECT OF THE ANTIPHOSPHOLIPID SYNDROME (APS) ON SURVIVAL IN 679 PATIENTS WITH SLE: A PROSPECTIVE STUDY

C.C. Mok - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

N/A

T CELL REACTIVITY TO ?2 GLYCOPROTEIN I IN SYSTEMIC LUPUS ERYTHEMATOSUS AND ANTI-PHOSPHOLIPID SYNDROME: CORRELATION WITH SUBCLINICAL ATHEROSCLEROSIS

F.R. Spinelli - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

N/A

SUBCLINICAL MYOCARDIAL DYSFUNCTION IN PRIMARY ANTIPHOSPHOLIPID SYNDROME ASSESSED BY SPECKLE TRACKING ECHOCARDIOGRAPHY

G. Medina - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

GLS4

CIRCULATING FREE PROTEIN S LEVELS MAY BE LINKED TO CARDIOVASCULAR EVENTS AND VENOUS THROMBOSIS IN SLE

G.J. Silverman - European League Against Rheumatism (EULAR) , 2012

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Venous thrombosis

L-Tyrosine

Filters

7277 Abstracts